![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 09, 2023 7:38:36 AM
It used to be 213m when gerpang healthcare bought $spom out. 120m went to fengyou, 20m to Jeff peng ( the current co ceo) 20m went to Meihua xu as a finders fee to get them in. They still own the shares according to the 2022 annual report.
The remaining shares went to pay out $spom's earlier debts. You can get those numbers from the financials. Approx 40m shares went to wipe out blue life's debt.
$spom was a dead shell before that. They had $25m negative retained earnings. They still have close to 21m. Gerpang healthcare had massive revenues.
In 2021 they had annual revenues of
$32m. 10m assets was added to balance sheet for $160m Shares . The shares had jumped to a high of 68c. China lockdowns and covid messed them up last year.
Now there is a new merger happening. New ceo. He has merged his 10m revenue company in here. (1.5m net profits) for new 55m shares. I think there is more to this. We will find out more on the next financials.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM